PharmaCorp Rx Inc. (TSXV:PCRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.4800
-0.0100 (-2.04%)
At close: May 12, 2026
Market Cap85.30M +51.5%
Revenue (ttm)20.89M +260.6%
Net Income-1.48M
EPS-0.01
Shares Out174.08M
PE Ration/a
Forward PE49.00
Dividendn/a
Ex-Dividend Daten/a
Volume29,420
Average Volume155,973
Open0.4900
Previous Close0.4900
Day's Range0.4800 - 0.4900
52-Week Range0.4000 - 0.5800
Beta-4.30
RSI55.40
Earnings DateMay 14, 2026

About PharmaCorp Rx

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. It offers prescription drug and custom compounding specialization services; weight loss and lifestyle management solutions, including health and wellness products; and convenience and confectionary products. The company was incorporated in 2021 and is headquartered in Saskatoon, Canada. [Read more]

Sector Healthcare
Founded 2021
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol PCRX
Full Company Profile

Financial Performance

In 2025, PharmaCorp Rx's revenue was 20.89 million, an increase of 260.57% compared to the previous year's 5.79 million. Losses were -1.48 million, 46.3% more than in 2024.

Financial Statements

News

PharmaCorp Rx Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference

At the 2026 Bloom Burton Healthcare Investor Conference, a pharmacy roll-up firm detailed its exclusive acquisition pipeline, flexible exit options for owners, and focus on operational stability and top-line growth. Recent capital raised will fund further expansion and team growth.

21 days ago - Transcripts